united therapeutics glp-1 receptor agonist Frontiers Understanding GLP-1 receptor agonists and

And now here you are talking about the brain

For patients with severe obesity and metabolic disease, this is a giftlife-extending, even lifesaving

While this is part of how they help with appetite and weight, it can also lead to: Acid reflux A feeling of fullness or pressure Disrupted sleep (especially if reflux worsens at night) Even if youve been taking Akkermansia, it may not fully offset this effect because the root issue here is mechanical (slower stomach emptying) rather than purely microbial

Despite concerns over affordability and side effects, in May, analysts at Morgan Stanley Research predicted the global obesity drug market could peak at $150 in 2035, up from the firms previous forecast of $105 billion

(2025) 8:e2457349

These findings underscore the enhanced therapeutic potential of dual incretin receptor activation in achieving robust and sustained metabolic improvements